J. Scott Garland Insider Trading $RLYP Relypsa Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for J. Scott Garland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J. Scott Garland. J. Scott Garland is EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Karyopharm Therapeutics Inc. ($KPTI).
J. Scott Garland in Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: SVP & Chief Commercial Officer
Holdings: 18,512 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J. Scott Garland in Relypsa Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | D | 28.38 | 35,000 | 993,300 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | D | 21.36 | 100,000 | 2,136,000 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | D | 18.87 | 25,000 | 471,750 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | A | 18.87 | 16,667 | 314,506 | 25,000 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Sell | D | 32.00 | 16,042 | 513,344 | 0 | 16 K to 0 (-100.00 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Sell | U | 32.00 | 2,470 | 79,040 | 16,042 | 18.5 K to 16 K (-13.34 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,167 | 0 | 18,512 | 14.3 K to 18.5 K (+29.05 %) |
| Aug 17 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Payment of Exercise | F | 31.89 | 705 | 22,482 | 14,345 | 15.1 K to 14.3 K (-4.68 %) |
| Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | A | 18.87 | 8,333 | 157,244 | 8,333 | |
| Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Payment of Exercise | F | 19.96 | 783 | 15,629 | 15,050 | 15.8 K to 15.1 K (-4.95 %) |
| Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 2,083 | 0 | 15,833 | 13.8 K to 15.8 K (+15.15 %) |
| Nov 10 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 6,250 | 0 | 13,750 | 7.5 K to 13.8 K (+83.33 %) |
| Aug 12 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | A | 28.38 | 35,000 | 993,300 | 35,000 | |
| Aug 12 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Page: 1